Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years. 

AVR patients may require a longer hospitalization if they present with pre-existing or new-onset AFib.

The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.

Frailty measurements may still provide helpful information in other ways, of course. 

The blood-based biomarker was previously associated with worse acute coronary syndrome outcomes. What does it mean for TAVR patients?

The study's authors examined new TAVR programs established from 2012 to 2018.

One-year outcomes are similar when patients undergo PCI prior to TAVR—except for one important difference.